Merck & Co Inc $59.52

down -0.03


15/9/2014 04:01 PM  |  NYSE : MRK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get MRK Trend Analysis - it has outperformed the S&P 500 by 7%

Partner Headlines

  1. Is Merck & Co., Inc. A Leader In A Red Hot Market?

    Benzinga
  2. Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin ...

    Benzinga
  3. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD
  4. 4 Biotechs That Might Be Bought Soon

    IBD
  5. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus
  6. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus
  7. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga
  8. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga
  9. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga
  10. UPDATE: Deutsche Bank Initiates Coverage On Merck

    Benzinga
  11. Merck, Pfizer combining drugs

    IBD
  12. Fast Money Halftime Report Final Trade From August 26

    Benzinga
  13. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD
  14. Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer ...

    Benzinga
  15. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  16. Advaxis, Merck to Collaborate on Investigational Combination of Two Novel ...

    Benzinga
  17. Achillion Pharmaceuticals Up On Buyout Rumors

    IBD
  18. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  19. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  20. Stocks Backslide Into Losses; Jazz Pharma, Kinder Morgan Rise

    IBD
  21. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  22. Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP ...

    Benzinga
  23. UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid

    Benzinga
  24. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  25. Legendary Investor Irving Kahn's Top Five Stocks

    GuruFocus
  26. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  27. 3 Reasons to Buy Merck for the Long Term

    Benzinga
  28. Len Schleifer's Science Focus Pays Off At Regeneron

    IBD
  29. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  30. Amgen To Slash Workforce

    IBD
  31. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  32. Pharmaceutical ETFs Are Health Care Sector Standouts

    Benzinga
  33. Indices Remain Mixed; Merck Beats Expectations

    Benzinga
  34. Tuesday Morning Earnings Releases

    Benzinga
  35. Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher

    Benzinga
  36. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD
  37. Markets Open Higher; Merck Posts Upbeat Profit

    Benzinga
  38. Stocks Climb In Early Trade; Herbalife, El Pollo Loco Dive

    IBD
  39. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  40. US Stock Futures Rise Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  41. UPDATE: Merck Q2 Profit Beats Street View, Shares Rise

    Benzinga
  42. Earnings Scheduled For July 29, 2014

    Benzinga
  43. Stocks To Watch For July 29, 2014

    Benzinga
  44. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  45. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  46. Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And ...

    Benzinga
  47. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  48. Week Ahead: July Jobs Report, FOMC and GDP

    FoxBusiness
  49. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  50. UnitedHealth Group Up on Weak Day for the Dow

    GuruFocus
Trading Center